Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
601.00Today’s High
677.0052W low
282.9052W High
677.00Open Price
601.00Prev. Close
526.7500Volume
4211867.00Value
2780674593.40Fundamentals
Market Cap
6456.20
Price to Earnings
202.80
Price to Book Value
3.60
Dividend Yield
0.00
PE to Growth
1.00
Op Revenue TTM
1151.33
Net Profit TTM
31.84
Cash From Operating Activity
135.34
Return on Equity %
1.76
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
20.7
Week
25.7
Month
39.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
646.07
PIVOT
First Resistance
691.13
Second Resistance
722.07
Third Resistance
767.13
First Support
615.13
Second Support
570.07
Third Support
539.13
Relative Strength Index
73.76
Money Flow Index
84.4
MACD
24.12
MACD Signal
18.97
Average True Range
29.92
Average Directional Index
25.43
Rate of Change (21)
34.67
Rate of Change (125)
97.02
Commodity Channel Index
248.3
Williams %R
-10.7
BETA
1 Month
1.49
3 Month
1.1
1 Year
0.75
3 Year
0.17
PRICE CHANGE ANALYSIS
↑ 17.43%
1 Week
Low
High
559
677
↑ 46.47%
1 Month
Low
High
444.1
677
↑ 33.7%
3 Months
Low
High
417.6
677
↑ 98.41%
6 Months
Low
High
313.15
677
↑ 116.81%
1 Year
Low
High
282.9
677
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 110.70 | 86.31 | 97.38 | 104.52 | 86.83 | 69.24 | 86.82 | 73.46 | 83.21 | 289.64 | 294.98 | |
| Operating Expenses Qtr | 80.49 | 67.28 | 67.32 | 68.40 | 80.27 | 61.90 | 93.21 | 56.33 | 74.42 | 220.10 | 221.94 | |
| Operating Profit Qtr | 6.96 | -3.30 | 7.29 | 15.34 | -13.77 | -10.26 | -24.48 | 4.50 | -1.55 | 56.54 | 63.93 | |
| EBIDT Qtr Cr | 26.42 | 18.91 | 29.84 | 29.78 | -8.40 | 7.34 | -4.52 | 121.35 | 47.09 | 69.55 | 81.95 | |
| Depreciation Qtr | 12.29 | 12.39 | 12.67 | 12.26 | 11.98 | 12.26 | 11.89 | 10.42 | 10.29 | 14.61 | 13.13 | |
| Net Profit Qtr | 9.74 | 2.70 | 6.60 | 7.90 | -28.93 | -4.79 | -17.17 | 108.08 | 35.45 | 36.77 | 43.62 | |
| Basic EPS Qtr | 1.12 | 0.31 | 0.76 | 0.91 | -3.33 | -0.55 | -1.98 | 12.45 | 4.08 | 4.36 | 5.35 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 398.90 | 316.35 | 397.81 | 289.30 | 817.23 | |
| Operating Expenses Annual Cr | 283.50 | 291.70 | 335.27 | 223.68 | 561.07 | |
| Operating Profit Annual | 26.29 | -44.00 | 21.69 | 33.37 | 244.91 | |
| Operating Profit Margin Annual % | 6.59 | -13.91 | 5.45 | 11.54 | 29.97 | |
| Total Expenses Annual Cr | 350.36 | 359.08 | 379.14 | 252.03 | 600.35 | |
| EBIDT Annual Cr | 115.41 | 24.64 | 62.55 | 65.62 | 256.17 | |
| EBIDT Annual margin % | 28.93 | 7.79 | 15.72 | 22.68 | 31.35 | |
| Depreciation | 49.61 | 46.55 | 34.82 | 22.28 | 34.96 | |
| PAT Before ExtraOrdinary Items Annual Cr | 26.94 | -49.48 | 20.16 | 65.09 | 168.19 | |
| Net Profit Annual | 26.94 | 57.19 | 140.99 | 184.39 | 193.72 | |
| Basic EPS Annual | 3.10 | 6.59 | 16.24 | 22.62 | 20.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2142.72 | 2117.58 | 2065.67 | 1637.83 | 1453.42 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 49.53 | 158.37 | 210.15 | 405.58 | 208.00 | |
| Total Current Liabilities Annual Cr | 226.34 | 241.41 | 620.30 | 473.98 | 359.86 | |
| Total Capital Plus Liabilities Annual Cr | 2418.59 | 2517.36 | 2896.12 | 2517.39 | 2021.28 | |
| Fixed Assets Annual | 814.57 | 835.36 | 858.89 | 1123.24 | 889.81 | |
| Total Non Current Assets Annual | 2041.66 | 1882.41 | 1692.22 | 1737.50 | 1113.59 | |
| Total Current Assets Annual | 376.93 | 634.95 | 1203.90 | 779.90 | 907.69 | |
| Total Assets Annual | 2418.59 | 2517.36 | 2896.12 | 2517.39 | 2021.28 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 510.05 | 374.38 | 207.79 | 40.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 8.03 | 2.08 | 173.87 | 69.63 | 129.79 | |
| Cash from Investing Activity Annual | 155.82 | -94.80 | -378.97 | -238.13 | -295.08 | |
| Cash from Financing Annual Activity | -163.07 | 87.68 | 97.23 | 255.58 | 170.10 | |
| Net Cash Flow Annual | - | -5.04 | -107.88 | 87.08 | 4.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 246.85 | 243.96 | 237.97 | 200.89 | 178.27 | |
| ROE Annual % | 1.25 | 2.70 | 6.82 | 11.25 | 13.32 | |
| ROCE Annual % | 3.00 | -0.96 | 1.21 | 2.12 | 13.31 | |
| Total Debt to Total Equity Annual | 0.07 | 0.14 | 0.09 | 0.40 | 0.22 | |
| EBDIT Annual Margin % | 37.25 | 9.94 | 17.52 | 25.52 | 31.78 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 294.19 | 288.70 | 314.79 | 262.11 | 265.73 | 265.24 | 267.29 | 269.26 | 346.09 | 277.78 | 296.55 | |
| Operating Expenses Qtr | 221.63 | 220.54 | 252.68 | 212.26 | 225.34 | 231.21 | 250.71 | 240.59 | 266.87 | 227.21 | 242.11 | |
| Operating Profit Qtr | 70.06 | 65.94 | 60.30 | 47.92 | 38.23 | 31.29 | 12.20 | 20.57 | 73.73 | 45.09 | 53.16 | |
| EBIDT Qtr Cr | 78.68 | 68.16 | 62.11 | 49.85 | 40.40 | 34.03 | 16.58 | 28.67 | 79.10 | 50.57 | 63.35 | |
| Depreciation Qtr | 26.63 | 26.71 | 27.79 | 26.75 | 25.69 | 24.08 | 23.31 | 22.42 | 22.34 | 20.65 | 19.18 | |
| Net Profit Qtr | 24.50 | 4.58 | 1.57 | 1.18 | -8.04 | -6.62 | -18.66 | 0.85 | 29.55 | 9.56 | 19.96 | |
| Basic EPS Qtr | 2.82 | 0.53 | 0.19 | 0.14 | -0.93 | -0.76 | -2.15 | 0.10 | 3.40 | 1.13 | 2.45 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1159.77 | 1067.51 | 1159.77 | 931.27 | 924.85 | |
| Operating Expenses Annual Cr | 907.11 | 947.83 | 941.67 | 719.48 | 688.11 | |
| Operating Profit Annual | 244.50 | 102.28 | 203.86 | 181.65 | 219.80 | |
| Operating Profit Margin Annual % | 21.08 | 9.58 | 17.58 | 19.51 | 23.77 | |
| Total Expenses Annual Cr | 1106.79 | 1101.98 | 1062.63 | 795.32 | 736.45 | |
| EBIDT Annual Cr | 252.67 | 119.68 | 218.10 | 211.79 | 236.74 | |
| EBIDT Annual margin % | 21.79 | 11.21 | 18.81 | 22.74 | 25.60 | |
| Depreciation | 107.87 | 95.50 | 79.80 | 53.98 | 43.78 | |
| PAT Before ExtraOrdinary Items Annual Cr | 36.73 | -27.11 | 64.24 | 147.94 | 154.91 | |
| Net Profit Annual | 31.87 | -32.48 | 60.66 | 147.78 | 156.15 | |
| Basic EPS Annual | 3.67 | -3.74 | 7.26 | 18.13 | 19.15 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1808.69 | 1783.28 | 1822.19 | 1478.69 | 1329.36 | |
| Minority Interest Liability Annual Cr | -8.74 | -8.92 | -11.05 | -11.17 | -7.91 | |
| Total Non Current Liabilities Annual Cr | 599.90 | 345.11 | 452.82 | 567.87 | 256.94 | |
| Total Current Liabilities Annual Cr | 693.35 | 782.91 | 611.54 | 602.16 | 407.74 | |
| Total Capital Plus Liabilities Annual Cr | 3093.20 | 2902.38 | 2875.50 | 2637.55 | 1986.13 | |
| Fixed Assets Annual | 2030.14 | 1978.14 | 1802.30 | 1607.63 | 1279.70 | |
| Total Non Current Assets Annual | 2216.38 | 2134.37 | 1988.30 | 1719.50 | 1365.35 | |
| Total Current Assets Annual | 876.83 | 768.01 | 887.19 | 918.05 | 620.78 | |
| Total Assets Annual | 3093.20 | 2902.38 | 2875.50 | 2637.55 | 1986.13 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 186.39 | 103.86 | 47.85 | 50.99 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 135.34 | 226.17 | 105.13 | 47.07 | 123.72 | |
| Cash from Investing Activity Annual | -166.58 | -278.48 | -285.50 | -404.28 | -288.85 | |
| Cash from Financing Annual Activity | 46.77 | 45.80 | 82.86 | 436.37 | 175.50 | |
| Net Cash Flow Annual | - | -6.51 | -97.51 | 79.17 | 10.38 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 207.36 | 204.41 | 208.65 | 180.00 | 162.09 | |
| ROE Annual % | 1.76 | -1.82 | 3.32 | 9.99 | 11.74 | |
| ROCE Annual % | 6.03 | 1.14 | 6.10 | 7.75 | 12.22 | |
| Total Debt to Total Equity Annual | 0.52 | 0.45 | 0.37 | 0.49 | 0.25 | |
| EBDIT Annual Margin % | 21.94 | 11.39 | 19.03 | 23.50 | 26.07 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| AKASH BHANSHALI | 1.64 | 75279229 | - | - |
| ELM PARK FUND LIMITED | 1.23 | 75279216 | - | - |
| ICICI PRUDENTIAL INNOVATION FUND | 3.3 | 75279208 | - | - |
| VIRAL AMAL PARIKH | 1.02 | 75279230 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| VISHNUKANT CHATURBHUJ BHUTADA | 6.51 | 75279183 | 100 | 0 |
| DHARMAVATI BHUTADA | 6.35 | 75279184 | 100 | 0 |
| RAVI KUMAR INNANI | 4.1 | 75279185 | 100 | 0 |
| SURAJ KUMAR INNANI | 4.07 | 75279186 | 0 | 0 |
| OM PRAKASH INANI | 2.93 | 75279187 | 100 | 0 |
| DEEPAK KUMAR INNANI | 2.8 | 75279188 | 100 | 0 |
| KANTADEVI INANI | 2.6 | 75279189 | 100 | 0 |
| KESHAV BHUTADA | 2.05 | 75279190 | 100 | 0 |
| MADHAV VISHNUKANT BHUTADA | 2.05 | 75279191 | 100 | 0 |
| RAMAKANT INNANI | 1.53 | 75279192 | 100 | 0 |
| VISHNUKANTH C BHUTADA | 1.37 | 75279193 | 100 | 0 |
| TARADEVI INNANI | 1.28 | 75279194 | 100 | 0 |
| VISHNUKANTA INANI | 1.24 | 75279195 | 100 | 0 |
| BRIJGOPAL INNANI | 1.2 | 75279196 | 100 | 0 |
| NATAMAL INNANI | 1.16 | 75279197 | 100 | 0 |
| SHAKUNTALABAI INNANI | 1.15 | 75279198 | 100 | 0 |
| SAGAR INNANI | 1.02 | 75279199 | 100 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ICICI PRUDENTIAL INNOVATION FUND | 3.3 | 75279208 |
| BANDHAN CORE EQUITY FUND | 1.15 | 75279209 |
| COHESION MK BEST IDEAS SUB-TRUST | 2.12 | 75279219 |
| DOVETAIL INDIA FUND CLASS 6 SHARES | 1.52 | 75279215 |
| ELM PARK FUND LIMITED | 1.23 | 75279216 |
| TROO CAPITAL LTD | 1.12 | 75279217 |
| SBI LIFE INSURANCE CO. LTD | 1.12 | 75279211 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| AKASH BHANSHALI | 1.64 | 75279229 |
| VIRAL AMAL PARIKH | 1.02 | 75279230 |
| HUF | 0.89 | 75279221 |
| PIVOTAL ENTERPRISES PRIVATE LIMITED | 2.25 | 75279225 |
| SAPPHIRE INTREX LIMITED | 1.09 | 75279226 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 19, 2022 | 1.1 | FINAL | - | Equity Share |
| Sep 20, 2021 | 1.1 | FINAL | - | Equity Share |
| Mar 16, 2020 | 1.1 | INTERIM | Mar 17, 2020 | Equity Share |
| Sep 12, 2019 | 1 | FINAL | - | Equity Share |
| Mar 01, 2018 | 0.7 | INTERIM | Mar 05, 2018 | Equity Share |
| Mar 21, 2017 | 0.6 | INTERIM | Mar 22, 2017 | Equity Share |
| Mar 28, 2016 | 0.6 | INTERIM | Mar 29, 2016 | Equity Share |
| Sep 16, 2015 | 1.1 | FINAL | - | Equity Share |
| Sep 11, 2014 | 1 | FINAL | - | Equity Share |
| Jul 16, 2013 | 1.3 | FINAL | - | Equity Share |
| Sep 17, 2012 | 0.9 | FINAL | - | Equity Share |
| Sep 15, 2011 | 0.8 | FINAL | - | Equity Share |
| Sep 16, 2010 | 0.7 | FINAL | - | Equity Share |
| Sep 24, 2009 | 0.5 | FINAL | - | Equity Share |
| Sep 11, 2008 | 0.4 | FINAL | - | Equity Share |
| May 24, 2007 | 2 | INTERIM | May 26, 2007 | Equity Share |
| Sep 23, 2005 | 1.5 | FINAL | - | Equity Share |
| Sep 11, 2002 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Nov 06, 2015 | 2:1 | - |
| Sep 28, 2007 | 10:2 | 2007-10-08 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 23, 2024 | Audited Results & Final Dividend | - |
| Feb 08, 2024 | Quarterly Results | - |
| Nov 10, 2023 | Quarterly Results | - |
| Aug 10, 2023 | Quarterly Results | - |
| Jun 23, 2023 | Rights issue of Equity Shares | - |
| May 25, 2023 | Audited Results | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 11, 2022 | Quarterly Results | - |
| May 23, 2022 | Audited Results & Dividend | - |
| Feb 08, 2022 | Quarterly Results | - |
| Oct 29, 2021 | Quarterly Results | - |
| Oct 14, 2021 | Preferential issue of shares | - |
| Aug 14, 2021 | Quarterly Results | - |
| May 31, 2021 | Audited & Quarterly Results | - |
| Feb 13, 2021 | Quarterly Results | - |
| Nov 02, 2020 | Quarterly Results | - |
| Aug 08, 2020 | Quarterly Results | - |
| Jun 15, 2020 | Audited Results | - |
| Mar 06, 2020 | Interim Dividend | - |
| Feb 10, 2020 | Quarterly Results | - |
| Nov 09, 2019 | Quarterly Results | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 27, 2019 | Audited Results & Dividend | - |
| Feb 07, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 13, 2018 | Quarterly Results | - |
| May 28, 2018 | Audited Results | - |
| Feb 22, 2018 | Interim Dividend | - |
| Feb 13, 2018 | Quarterly Results | - |
| Nov 13, 2017 | Quarterly Results | - |
| Aug 10, 2017 | Quarterly Results | - |
| May 29, 2017 | Audited Results | - |
| Mar 09, 2017 | Others | To consider, inter alia, declaration of interim dividend. |
| Feb 14, 2017 | Quarterly Results | - |
| Dec 26, 2016 | Allotment of Equity Shares | - |
| Dec 01, 2016 | Others | To consider the issue of Equity Shares OR Convertible Securities on Preferential basis under SEBI (ICDR) Regulations, 2009. |
| Nov 25, 2016 | Quarterly Results | - |
| Aug 26, 2016 | Quarterly Results | - |
| Jun 27, 2016 | Others | Inter alia, to consider a proposal of merger of Navya Boilogicals Private Limited with the Company. |
| May 30, 2016 | Audited Results | - |
| Mar 17, 2016 | Interim Dividend | - |
| Feb 12, 2016 | Quarterly Results | - |
| Nov 07, 2015 | Quarterly Results | - |
| Aug 12, 2015 | Stock Split | - |
| Aug 07, 2015 | Quarterly Results | - |
| May 29, 2015 | Audited Results & Dividends | - |
| Mar 17, 2015 | Interim Dividend | - |
| Feb 14, 2015 | Quarterly Results | - |
| Nov 14, 2014 | Quarterly Results | - |
| Aug 14, 2014 | Quarterly Results | - |
| May 29, 2014 | Audited Results & Dividend | - |
| Apr 11, 2014 | Others | To consider the proposal for offer and issue of Equity Shares or Warrants or convertible instruments on preferential basis. |
| Feb 10, 2014 | Quarterly Results | - |
| Nov 09, 2013 | Quarterly Results | - |
| Aug 14, 2013 | Quarterly Results | - |
| May 29, 2013 | Audited Results & Dividend | - |
| Feb 11, 2013 | Quarterly Results | - |
| Nov 07, 2012 | Quarterly Results | - |
| Aug 10, 2012 | Audited, Quarterly Results & Dividend | For the quarter ended 30th June, 2012 & for the year ended 31st March, 2012. |
| May 14, 2012 | Quarterly Results | - |
| Feb 09, 2012 | Quarterly Results | - |
| Nov 12, 2011 | Quarterly Results | - |
| Aug 11, 2011 | Audited, Quarterly Results & Dividend | - |
| May 12, 2011 | Quarterly Results | - |
| Jan 28, 2011 | Quarterly Results | - |
| Oct 27, 2010 | Quarterly Results | - |
| Sep 01, 2010 | Audited Results & Dividend | - |
| Aug 16, 2010 | Issue of Shares / Warrants / CBs | To issue of 5,00,000 Equity Shares or Warrants carrying a right to subscribe to equal no. of Equity Shares of Rs. 2/- each of the Co. & to issue of 20,00,000 Equity Shares of Rs. 2/- each. |
| Jul 28, 2010 | Quarterly Results | - |
| Apr 29, 2010 | Quarterly Results | - |
| Jan 25, 2010 | Quarterly Results | - |
| Oct 21, 2009 | Quarterly Results | - |
| Aug 31, 2009 | Audited Results & Dividend | - |
| Jul 22, 2009 | Quarterly Results | - |
| Apr 27, 2009 | Quarterly Results | - |
| Jan 19, 2009 | Quarterly Results & Others | To take on record the Decree passed by the High Court of Karnataka transferring the assets of erstwhile Shilpa Organics Pvt Ltd to Shilpa Medicare Ltd. |
| Oct 20, 2008 | Quarterly Results | - |
| Jul 29, 2008 | Quarterly Results | - |
| Jun 30, 2008 | Audited Results & Dividend | - |
| Jan 25, 2008 | Quarterly Results | - |
| Oct 24, 2007 | Quarterly Results | - |
| Jul 25, 2007 | Audited Results & Quarterly Results | - |
| May 18, 2007 | Interim Dividend | - |
| Apr 26, 2007 | Stock Split & Quarterly Results | - |
| Feb 07, 2007 | Others | To discuss the feasibility and exploring the possibility of Joint Venture / Expansion / acquisition of any new unit in India or abroad among other things & discuses the various other matters. |
| Jan 27, 2007 | Quarterly Results | - |
| Oct 27, 2006 | Quarterly Results | - |
| Sep 05, 2006 | Scheme of Amalgamation | To consider the revised Scheme of Amalgamation of Shilpa Organics (P) Ltd with the Company. |
| Jul 21, 2006 | Quarterly Results | - |
| Apr 27, 2006 | Quarterly Results | - |
| Feb 06, 2006 | Re-issue of forfeited equity shares | - |
| Jan 27, 2006 | Quarterly Results | - |
| Nov 21, 2005 | Re-issue of forfeited shares | To consider reissue of forfeited shares. |
| Oct 31, 2005 | Quarterly Results | - |
| Oct 14, 2005 | Preferential Issue of shares | - |
| Sep 03, 2005 | Preferential Issue | - |
| Aug 29, 2005 | Merger of Shilpa Organic (P) Ltd. | To consider a proposal for merger of Shilpa Organic (P) Ltd. with the comapny. |
| Jul 30, 2005 | Quarterly Results | - |
| Apr 30, 2005 | Quarterly Results | - |
| Jan 31, 2005 | Quarterly Results | - |
| Oct 31, 2004 | Quarterly Results | - |
| Jul 31, 2004 | Quarterly Results | - |
| Apr 30, 2004 | Quarterly Results | - |
| Jan 31, 2004 | Quarterly Results | - |
| Oct 31, 2003 | Quarterly Results | - |
| Aug 14, 2003 | Others | To discuss forfeiture of partly paid shares. |
| Jul 31, 2003 | Quarterly Results | - |
| Apr 30, 2003 | Quarterly Results | - |
| Jan 31, 2003 | Quarterly Results | - |
| Oct 31, 2002 | Quarterly Results | - |
| Jul 31, 2002 | Quarterly Results | - |
| May 31, 2002 | Quarterly Results | - |
| Jul 31, 2001 | Quarterly Results | - |
| Apr 30, 2001 | U.A. Financial Results | - |
| Jan 31, 2001 | Quarterly Results | - |
| Oct 31, 2000 | Quarterly Results | - |
| Jul 31, 2000 | Quarterly Results | - |
| May 31, 2000 | Unaudited Financial Results | - |
| Mar 30, 2000 | Interim Dividend | - |
| Jan 31, 2000 | Quarterly Results | - |
| Jul 31, 1999 | Quarterly Results | - |
| Apr 30, 1999 | Quarterly Results | - |
| Jan 30, 1999 | Quarterly Results | - |
| Oct 31, 1998 | Half Yearly Results | - |
| Nov 29, 1997 | Half Yearly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jul 16, 2013 | 1:2 | - |
05 Jul 2024
This pharma stock has surged 16% on Friday; zoomed over 100% so far in CY24
Shilpa Medicare hit a multi-year high of Rs 672.50, rallied 16% after the company's CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order.
05 Jul 2024
Stock Of The Day: Shilpa Medicare Rallies After Order For Kidney Disease Treatment Key Levels
Here is all you need to know about the Shilpa Medicare's order win, its impact and future plans.
04 Jul 2024
SHILPA MEDICARE LTD. - 530549 - Important Milestone For The CDMO Business Of Shilpa Medicare Limited ('SML')
Important milestone for the CDMO business of Shilpa Medicare Limited (SML) - Shilpa''s CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order
03 Jul 2024
SHILPA MEDICARE LTD. - 530549 - Credit Rating - Shilpa Pharma Life Sciences Limited - Material Subsidiary Of Shilpa Medicare Limited , Holding Company
Credit Rating - Shilpa Pharma Life Sciences Limited - Material Subsidiary of Shilpa Medicare Limited, Holding Company
25 Jun 2024
SHILPA MEDICARE LTD. - 530549 - USFDA Inspection Close-Out Of Bio-Analytical Laboratory, Unit 7, Shilpa Medicare Limited, Nacharam, Hyderabad, Telangana.
USFDA inspection close out of Bio-Analytical Laboratory, Unit 7, Shilpa Medicare Limited, Nacahram, Hyderabad
19 Jun 2024
SHILPA MEDICARE LTD. - 530549 - Re-Designation Of Mr. Keshav Bhutada As Executive Director In Shilpa Pharma Lifesciences Ltd, A Material Subsidiary Of Shilpa Medicare Limited, On A Remuneration Of INR 1.00 Cr. (Rupees One Crore Only) Per Annum W.E.F 19 June, 2024 And Payment Of Remuneration Of INR 1.00 Cr. (Rupees One Crore Only) Per Annum W.E.F 1St April, 2024, To Mr. Madhav Bhutada, Managing Director, Shilpa Biocare Pvt. Limited, Wholly Owned Subsidiary Of Shilpa Medicare Limited, Subject To Members Approval In The Ensuing General Meeting
Re- designation of Mr. Keshav Bhutada as Executive Director in Shilpa Pharma Lifesciences Ltd, a material subsidiary of Shilpa Medicare Limited, on a remuneration of INR 1.00 Cr. (Rupees One Crore only) per annum w.ef 19 June, 2024 and payment of remuneration of INR 1.00 Cr. (Rupees One Crore only) per annum w.e.f. 1 April, 2024 to Mr. Madhav Bhutada , Managing Director, Shilpa Biocare Pvt. Ltd, a wholly owned subsidiary of Shilpa Medicare Limited, subject to members approval in the ensuing general meeting.
